SCHEMBL24210488

SCHEMBL24210488

CCC1CCc2cccc(Cl)c2C1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
PNMT P11086 1/20 0.41
HTR1A P08908 4/20 0.40
HTR7 P34969 4/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
CYP1A2 P05177 1/20 0.38
DRD2 P14416 1/20 0.38
TSHR P16473 1/20 0.38
HTR1D P28221 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686717 0.84 ADRA2A (0.41) CYP2D6ADRA2AADRA2BADRA2CADRA1D
SCHEMBL10247785 0.84 ADRA2A (0.41) CYP2D6ADRA2AADRA2BADRA2CADRA1D
SCHEMBL24210469 0.80 DRD2 (0.48) HTR1AHTR7CHRM2CHRM1CHRM3
SCHEMBL16233586 0.77 ADRA2A (0.49) CYP2D6ADRA2AADRA2BADRA2CADRA1D
SCHEMBL20131349 0.77 HTR7 (0.63) HTR1AHTR7
SCHEMBL9183738 0.76 DRD2 (0.58) CYP2D6ADRA1AADRA1BHTR1AHTR7
SCHEMBL9759195 0.75 DRD2 (0.52) CHRM2CHRM1CHRM3DRD2DRD3
Hydrochloric Acid SCHEMBL6961243 0.75 DRD2 (0.57) CYP2D6ADRA1AADRA1BHTR1AHTR7
SCHEMBL599314 0.74 CYP19A1 (0.54) ADRA1DADRA1AADRA1BHTR1A
SCHEMBL8315435 0.74 HTR1A (0.71) CYP2D6ADRA1AADRA1BHTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017541-A1 INHIBITORS OF ARGINASE Praxis Biotech LLC 2022-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017541-A1 INHIBITORS OF ARGINASE ARG1, ARG2, ARGLU1 CYP2D6 2935/4885ADRA2A 3155/4885ADRA2B 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.